A few things to keep in mind while reading: side effect percentages come from different clinical trials with different populations, durations, and designs, so direct comparisons have limitations
Increasing physician preference for GLP-1 receptor agonists due to their glycemic control benefits, cardiovascular risk reduction, and weight management capabilities continues to strengthen market leadership across the region
How injectable/oral GLP-1 medications work: Mimic the GLP-1 hormone with engineered modifications for extended duration Bind to GLP-1 receptors to enhance insulin release and reduce glucagon Slow gastric emptying by 20-50%, promoting satiety Supported by large randomized controlled trialsthe STEP trials showed 14.9% mean weight loss at 68 weeks versus 2.4% for placebo The short answer on why patches cant deliver these drugs: GLP-1 molecules are relatively large peptide chains (molecular weight 3-5 kDa) that cannot effectively penetrate the skin barrier through passive transdermal diffusion
Important: This Isn't a Quick Fix GLP-1 medications work best as part of a comprehensive approach: Consistent medication use (if prescribed) Healthy nutrition habits Regular physical activity Stress management Adequate sleep Support and coaching Virtual WeightCare provides all of these components
Duplechain and his team for GLP-1 treatment and could not be happier with the quality of care they provide
Considering GLP-1 is released in the intestine after eating, choose to consume the right foods that will trigger its release and avoid those that will negatively affect GLP-1 secretion
